European Archives - Page 486 of 1103 - European Medical Journal

The risks, rewards and future potential of biotechnology

In this episode, Marc and Helena have a chat about biotech with special guest Claire Skentelbery, Director General of EuropaBio.

Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy

The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…

EMJ Hematology 10 [Supplement 4] 2022

Myelodysplastic syndromes (MDS) are a rare group of blood disorders that can result in symptoms spanning from fatigue to easy bruising and bleeding. Based on a symposium that was part of the International Congress on Myelodysplastic Syndromes by the MDS Foundation, this article provides an overview of MDS.

David Oliver

Interview: David Oliver

David Oliver shared his thoughts with EMJ on his leadership and policy experience, his passion for advocacy in healthcare, and his work in…

EMJ 7.1 2022 Feature Image

EMJ 7.1 2022

Welcome to our first flagship EMJ journal of the year that has a mini-focus on COVID-19, sharing case studies alongside our article…

EMJ 7.1 2022 Feature Image

Science Versus COVID-19: What Have We Learnt So Far?

TWO YEARS AGO, the COVID-19 pandemic emerged and swept through the world, going on to have a profound human and health toll…

EMJ 7.1 2022 Feature Image

Editor’s Pick: Thromboembolic Storm in the Recovering Stage of COVID-19: A Case Report

COVID 19 was first identified in late 2019 and led to a worldwide pandemic. Covid complications include thromboembolic storm…

EMJ 7.1 2022 Feature Image

Utility of Evidence-Based Clinical Decision Support in Reducing Unwarranted Variations in Diagnosis and Treatment of Breast and Lung Cancer

It is clear that the delivery of advanced healthcare prolongs life. The global average life expectancy has almost doubled since 1900…

EMJ 7.1 2022 Feature Image

ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series

Patients with COVID 19 with associated myocardial infarction and myocarditis, requiring myocarditis treatment…

Reactive Hip Arthritis and Avascular Necrosis After Severe COVID-19

Reactive arthritis is an emerging musculoskeletal manifestation post-COVID-19 infection. This is the first case reported of hip arthritis and avascular necrosis following the COVID-19 infection.